
TSE:XHC
This summary was created by AI, based on 3 opinions in the last 12 months.
iShares S&P Global Healthcare (XHC) is regarded as one of the premier healthcare ETFs, particularly for investors looking into the healthcare sector outside of Canada. Experts suggest that for diversification, investors may want to consider US-based options such as IXJ alongside XHC. The ETF provides expansive coverage of large-cap healthcare companies across multiple segments including pharmaceuticals, healthcare products, and services, boasting well-known names like UnitedHealth Group (UNH). While it offers defensive and growth characteristics, the healthcare sector is still vulnerable to volatility from governmental actions, especially in the US, which may create fluctuations in performance. Investing in XHC, combined with strategies such as pairing it with HHL for income, may yield balanced exposure in a demographic environment favorable to healthcare, despite recent underperformance in the sector.
An interesting way to play the sector. You're not chasing performance, and you're doing it in a balanced way. Good sector for this strategy, as it's not as economically sensitive as others.
Have some that's written and some that's not, so you don't give up all the upside. Healthcare hasn't participated in the market rally, but things should normalize with clarity in the US. Demographic trend is pretty good.
Tracks the S&P 1200 Global Health Care Sector Index. Large and diversified pharma, biotech, medical devices, health services. Giant scope. Names such as JNJ, UNH, PFE. Healthcare is often defensive, tailwind of aging population.
This sector's been a laggard, some of the names have really been hurt, so maybe there's a catchup trade. When we're in an environment of high beta and high growth, money rotates out of the defensive sectors.
Healthcare ETF. Playing the global healthcare space. BMO has one with a currency hedge on it. Thinks Healthcare will be a good bet for the next 20-30 years. You have to look at what is in them. Pharma vs. Biotech are different stories. This one is mostly large Pharma, which has its challenges. Should be bought about $30 where there is good support.
This is a global basket of health care stocks. Chart shows a little bit of a correction that took place in the early part of the year. Had a strong run at the beginning of the year which is very unusual for healthcare. There has been a pull back which is fine because it did so well earlier on. It is now getting back close to the top. We are into the seasonal period for healthcare, which is in August. We are just a few weeks away from that so this is an attractive sector.
iShares S&P Global Healthcare is a Canadian stock, trading under the symbol XHC.TO (previously XHC-T on Stockchase) on the Toronto Stock Exchange (XHC-CT). It is usually referred to as TSX:XHC or XHC.TO
In the last year, 3 stock analysts published opinions about XHC.TO (previously XHC-T on Stockchase). 3 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is HOLD. Read the latest stock experts' ratings for iShares S&P Global Healthcare.
iShares S&P Global Healthcare was recommended as a Top Pick by Bill Carrigan on 2013-05-27. Read the latest stock experts ratings for iShares S&P Global Healthcare.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.
3 stock analysts on Stockchase covered iShares S&P Global Healthcare in the last year. It is a trending stock that is worth watching.
On 2026-06-09, iShares S&P Global Healthcare (XHC.TO) stock closed at a price of $69.30.
For healthcare, you really need to look south of the border. Limited offerings in Canada, where it's either marijuana or senior living.
Consider either IXJ or XHC, depending on what currency you want to purchase in. Broad-based, with major large-cap healthcare names. Pharma, healthcare products, services, and includes UNH. Likes the space, as you get both defensive and growth characteristics.
Yes, it is fairly steady, but healthcare is always subject to things happening from government (especially in the US) such as pricing pressure. So that could cause a bit of volatility.